MSD announced that the company has entered into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generics manufacturers. Read more.
Pages
- Contact us
- Copyright
- Forward-looking statement
- General PO terms and conditions
- Investor information
- MSD | Home
- Purchase order terms and conditions
- Responsible Vulnerability Disclosure Program of MSD
- Sitemap
- Stories
- Terms of use
- Thank you for contacting msdethics.com
- What we do
- Who we are
- History
- Sustainability
- Access to health
- Environmental sustainability
- Impact Venture Fund
- MSD Medical Outreach Program
- Philanthropy
- Advancing equity in cancer care
- Advancing patient-centered cancer care
- Advancing patient-centered cancer care in resource-limited countries
- Enhancing diabetes care through community outreach and support
- Expanding access to cancer care in Asia
- Global emergency response
- Improving access to high-quality diabetes care
- Improving access to HIV care in sub-Saharan Africa
- Improving health care access
- MSD Foundation
- Product donation programs
- Promoting equity in HIV/AIDS care
- Richard T. Clark Fellowship for Global Health
- Solutions for Healthy Communities
- Strengthening health systems’ resilience through immunization
- Strengthening our communities
- Sustainability resources
- Transparency disclosures
- Leadership
- Culture & values
- Diversity and inclusion
- Policies & positions
- Suppliers
- Research
- Areas of focus
- Areas of innovation
- Business development and licensing
- COVID-19
- Eyebiotech Limited (EyeBio)
- Immunology
- Meet our scientists
- Neuroscience
- Ophthalmology
- Our science in action
- Postdoctoral research fellows program
- Publications
- Safety Data Sheets
- Scientific capabilities
- Vaccines
- Where our science happens
- Infectious diseases
- Oncology
- Cardio-metabolic diseases
- Pipeline
- Discovery & development
- Clinical Trials
- Diversity in clinical trials
- Product patents
- U.S. product patent information
- Patients
- Media
Archives
Categories
- No categories